Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either I

DINO, INVA, PARR, GNW and PBF stand out as low price-to-sales stocks with promising upside potential

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Global biosecurity alarms are flashing after an incident at an anti-plague research facility in Sibe

Oppenheimer analyst Les Sulewski assumes Innoviva (NASDAQ:INVA) with a Outperform rating and anno

Innoviva (NASDAQ: INVA - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Re

Baird Financial Group Inc. acquired a new stake in Innoviva, Inc. (NASDAQ: INVA) during the second q

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified biopharmaceutical

Hsbc Holdings PLC acquired a new position in Innoviva, Inc. (NASDAQ: INVA) during the second quarter

WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics (IST), a subsidiary of Innoviva, In

Cantor Fitzgerald analyst Steve Seedhouse maintains Innoviva (NASDAQ:INVA) with a Overweight and

Innoviva is a company that is transitioning from a pure royalty-based business to a diversified heal

Innoviva (INVA) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Est

Innoviva (NASDAQ:INVA) reported quarterly losses of $(1.14) per share which missed the analyst conse

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a

Supernus Pharmaceuticals NASDAQ: SUPN and Indivior Pharmaceuticals announced a proposed all-stock, t

Dimensional Fund Advisors LP grew its holdings in shares of Innoviva, Inc. (NASDAQ: INVA) by 1.7% in

Nortiva Bio, Inc. (“Nortiva”) today announced its launch as a clinical-stage biopharmaceutical c

Company is advancing its proprietary LYNX™ drug delivery platform to develop oral therapies that las

LEXINGTON, Mass.--(BUSINESS WIRE)--Nortiva Bio, Inc. (“Nortiva”) today announced its launch as a cli

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that

WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Na

Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified biopharmaceutical

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Innoviva (NASDAQ:INVA) with a Buy a

  On Friday, 497 companies set new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  On Tuesday, 507 stocks hit new 52-week lows.

  During Friday's session, 574 stocks hit new 52-week lows.

  On Tuesday, 126 companies set new 52-week lows.

  On Friday, 122 stocks hit new 52-week lows.

  On Thursday, 529 companies set new 52-week lows.

  On Thursday, 108 companies set new 52-week lows.

    Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.

    During Friday's morning session, 137 companies made new 52-week highs.

    On Thursday morning, 159 companies achieved new highs for the year.

    Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.

    During Tuesday's morning trading, 101 companies set new 52-week highs.

    Before 10 a.m. ET on Monday, 201 companies set new 52-week highs.

  Thursday's morning session saw 167 companies set new 52-week highs.

On Tuesday, 154 stocks made new 52-week highs.

Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Monday